Twist Bioscience Corp
NASDAQ:TWST
Twist Bioscience Corp
Revenue
Twist Bioscience Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Twist Bioscience Corp
NASDAQ:TWST
|
Revenue
$262.4m
|
CAGR 3-Years
37%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Twist Bioscience Corp
Revenue Breakdown
Breakdown by Geography
Twist Bioscience Corp
Total Revenue:
245.1m
USD
|
Americas:
151.3m
USD
|
EMEA:
71.4m
USD
|
Asia Pacific:
22.5m
USD
|
Breakdown by Segments
Twist Bioscience Corp
Total Revenue:
245.1m
USD
|
Ngs Tools:
123.7m
USD
|
Synthetic Genes:
73.5m
USD
|
Antibody Discovery:
23.2m
USD
|
Oligo Pools:
14.5m
USD
|
Dna And Biopharma Libraries:
10.2m
USD
|
See Also
What is Twist Bioscience Corp's Revenue?
Revenue
262.4m
USD
Based on the financial report for Dec 31, 2023, Twist Bioscience Corp's Revenue amounts to 262.4m USD.
What is Twist Bioscience Corp's Revenue growth rate?
Revenue CAGR 5Y
52%
Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Twist Bioscience Corp have been 37% over the past three years , 52% over the past five years .